Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Gottlieb Leaves Vocal Legacy At FDA

Loeb & Loeb Life Sciences Co-Chair Scott Liebman is quoted on the implications of the recent departure of the Food and Drug Administration commissioner and important policy changes to monitor. 

Click here to read the article on Law360's website. Subscription may be required.